Income Statement
VOR BIOPHARMA INC.
VOR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
371.64 | 121.19 | 126.04 | 93.42 | 69.02 |
|
Research & Development
|
321.53 | 93.31 | 94.32 | 64.55 | 47.53 |
|
Selling, General & Administrative
|
50.11 | 27.88 | 31.72 | 28.87 | 21.49 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-371.64 | -121.19 | -126.04 | -93.42 | -69.02 |
|
Non-Operating Income
|
-324.34 | 4.27 | 8.17 | 1.32 | 0.12 |
|
Interest Income
|
5.87 | 4.27 | 8.17 | 1.32 | 0.12 |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-695.98 | -116.91 | -117.86 | -92.09 | -68.90 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-371.64 | -121.19 | -126.04 | -93.42 | -69.02 |
|
Earnings Per Share (Basic)
|
-70.50 | -1.70 | -1.75 | -2.33 | - |
|
Diluted EPS
|
-70.50 | -1.70 | -1.75 | -2.33 | - |
|
Weighted Average Shares
|
9.87 | 68.71 | 67.19 | 39.55 | - |
|
Diluted Weighted Avg Shares
|
9.87 | 68.71 | 67.19 | 39.55 | - |
|
Comprehensive Income
|
-695.96 | -116.82 | -117.17 | -92.86 | - |